Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.

Publication ,  Journal Article
Rao, PK; Barker, C; Coit, DG; Joseph, RW; Materin, M; Rengan, R; Sosman, J; Thompson, JA; Albertini, MR; Boland, G; Carson Iii, WE; DiMaio, D ...
Published in: J Natl Compr Canc Netw
February 2020

The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2020

Volume

18

Issue

2

Start / End Page

120 / 131

Location

United States

Related Subject Headings

  • Uveal Neoplasms
  • Tumor Burden
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Oncologists
  • Neoplasm Recurrence, Local
  • Melanoma
  • Medical Oncology
  • Humans
  • Eye Enucleation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rao, P. K., Barker, C., Coit, D. G., Joseph, R. W., Materin, M., Rengan, R., … Engh, A. (2020). NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019. J Natl Compr Canc Netw, 18(2), 120–131. https://doi.org/10.6004/jnccn.2020.0007
Rao, P Kumar, Christopher Barker, Daniel G. Coit, Richard W. Joseph, Miguel Materin, Ramesh Rengan, Jeffrey Sosman, et al. “NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.J Natl Compr Canc Netw 18, no. 2 (February 2020): 120–31. https://doi.org/10.6004/jnccn.2020.0007.
Rao PK, Barker C, Coit DG, Joseph RW, Materin M, Rengan R, et al. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019. J Natl Compr Canc Netw. 2020 Feb;18(2):120–31.
Rao, P. Kumar, et al. “NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.J Natl Compr Canc Netw, vol. 18, no. 2, Feb. 2020, pp. 120–31. Pubmed, doi:10.6004/jnccn.2020.0007.
Rao PK, Barker C, Coit DG, Joseph RW, Materin M, Rengan R, Sosman J, Thompson JA, Albertini MR, Boland G, Carson Iii WE, Contreras C, Daniels GA, DiMaio D, Durham A, Fields RC, Fleming MD, Galan A, Gastman B, Grossman K, Guild V, Johnson D, Karakousis G, Lange JR, ScM, Margolin K, Nath S, Olszanski AJ, Ott PA, Ross MI, Salama AK, Skitzki J, Swetter SM, Wuthrick E, McMillian NR, Engh A. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019. J Natl Compr Canc Netw. 2020 Feb;18(2):120–131.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2020

Volume

18

Issue

2

Start / End Page

120 / 131

Location

United States

Related Subject Headings

  • Uveal Neoplasms
  • Tumor Burden
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Oncologists
  • Neoplasm Recurrence, Local
  • Melanoma
  • Medical Oncology
  • Humans
  • Eye Enucleation